Rep. Mike Finn

Maddy summaryThis bill establishes a state-level Child Fatality Review Team within the Office of the Child Advocate to investigate deaths and near-deaths of children under 18. The state team will be composed of representatives from various agencies, including public health, law enforcement, and education, who will serve without pay. Its primary goal is to understand the causes of these tragedies and recommend changes to laws and policies to prevent future incidents. Additionally, the bill requires the creation of local review teams in each district to conduct similar investigations and follow protocols developed by the state team. Both state and local team members will undergo criminal background checks and will provide annual reports to the governor and legislature on their findings.

Maddy summaryThis bill amends Massachusetts state laws to update terminology regarding individuals with intellectual or developmental disabilities. Its primary function is to replace outdated terms like "handicapped persons" and "autistic" with modern, person-first language such as "persons with disabilities" and "individuals with disabilities." These changes affect various sections of Chapter 6 of the General Laws, which cover topics including employment weeks and general definitions used across state regulations. By standardizing this language, the legislation ensures that official documents and statutes reflect current respectful terminology without altering the substantive rights or programs available to these individuals.

Maddy summaryThis bill creates a new criminal offense specifically for assaulting or battering public transit workers while they are performing their duties. It defines the crime to include acts such as spitting, throwing bodily fluids, or flinging unspecified liquids at transit employees. Anyone convicted faces a prison sentence of at least 90 days and up to two and a half years, or a fine ranging from $500 to $5,000. The legislation also authorizes law enforcement to make warrantless arrests for these offenses when the transit worker is operating a vehicle.

Senate, January 29, 2024 --The committee on Consumer Protection and Professional Licensure, to whom was referred the petitions (accompanied by bill, Senate, No. 213) of Michael F. Rush for legislation relative to the licensure of appraisers; (accompanied by bill, Senate, No. 214) of Michael F. Rush and Paul McMurtry for legislation relative to the licensure of appraisers; and (accompanied by bill, House, No. 262) of Tackey Chan, Paul R. Feeney and others relative to the licensure of appraisers, report the accompanying bill (Senate, No. 2568).

Maddy summaryThis bill establishes a new Auto Damage Appraiser Licensing Board within the Division of Occupational Licensure to regulate professionals who assess vehicle damage. The board will consist of seven members appointed from the auto body repair industry, insurance companies, the Attorney General's office, and consumer representatives, with one member serving as chair. Key provisions include limiting members to two consecutive three-year terms and requiring vacancies to be filled within 60 days. The legislation aims to create a structured oversight body specifically for auto damage appraisers in Massachusetts.

Maddy summaryThis bill amends Massachusetts law to allow existing Class 1 motor vehicle dealers to appeal the licensing of new dealers if they believe the new applicants have not met legal requirements. The legislation grants current licensees the right to challenge these decisions within ten days, requiring the state registrar to review the case and issue a ruling within thirty days. If the registrar upholds the new license, the current dealer can further appeal the decision to a superior court justice for a summary hearing. These changes create a formal administrative and judicial process for existing businesses to contest the approval of competing dealers.

Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).